Evidence map›Paper›PMID 31343422›Full record

ReviewAmerican journal of clinical oncology2019

ENvironmental Dynamics Underlying Responsive Extreme Survivors (ENDURES) of Glioblastoma: A Multidisciplinary Team-based, Multifactorial Analytical Approach.

Sandra K Johnston, Paula Whitmire, Susan C Massey, Priya Kumthekar, Alyx B Porter, Natarajan Raghunand, Luis F Gonzalez-Cuyar, Maciej M Mrugala, Andrea Hawkins-Daarud, Pamela R Jackson and 8 more

Open access · greenAbstract readReview
In one paragraph

Review in American journal of clinical oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 1 country.

Sandra K JohnstonMathematical Neuro-Oncology Laboratory, Precision Neurotherapeutics Innovation Program.
Paula WhitmireMathematical Neuro-Oncology Laboratory, Precision Neurotherapeutics Innovation Program.
Susan C MasseyMathematical Neuro-Oncology Laboratory, Precision Neurotherapeutics Innovation Program.
Priya KumthekarDepartments of Neurology.
Alyx B PorterDepartments of Neurology.
Natarajan RaghunandDepartment of Cancer Physiology & Cancer Epidemiology.
Luis F Gonzalez-CuyarDepartment of Pathology, Neuropathology Division, University of Washington Medical Center, Seattle, WA.
Maciej M MrugalaDepartments of Neurology.
Andrea Hawkins-DaarudMathematical Neuro-Oncology Laboratory, Precision Neurotherapeutics Innovation Program.
Pamela R JacksonMathematical Neuro-Oncology Laboratory, Precision Neurotherapeutics Innovation Program.
Leland S HuRadiology.
Jann N SarkariaDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN.
Lei WangRadiology and Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL.
Robert A GatenbyCancer Biology and Evolution Program.
Kathleen M EganCancer Epidemiology Program, Moffitt Cancer Center, Tampa, FL.
Peter CanollDepartment of Pathology and Cell Biology, Division of Neuropathology, Columbia University School of Medicine, New York, NY.
Kristin R SwansonMathematical Neuro-Oncology Laboratory, Precision Neurotherapeutics Innovation Program.
ENDURES consortium
Neurology, Inc · USArizona State University · USColumbia University · USMayo Clinic in Arizona · USMoffitt Cancer Center · USNorthwestern University · USUniversity of Washington · USUniversity of Washington Medical Center · US

Funding

Trans Network ProjectU54CA210180 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WHITE, FOREST M · 2016 to 2020
$10.2M
The Physi(ologi)cal Microenvironment and its Role in Tumor Invasion and MetastaseU54CA143970 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI GATENBY, ROBERT A · 2009 to 2014
$9.3M
Patient-specific predictive modeling that integrates advanced cancer imagingR01CA164371 · NCI · UNIVERSITY OF WASHINGTON · PI KINAHAN, PAUL E., SWANSON, KRISTIN R · 2011 to 2015
$4.5M
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in GlioblastomaU01CA220378 · NCI · MAYO CLINIC ARIZONA · PI HU, LELAND, SWANSON, KRISTIN R · 2017 to 2021
$4.3M
Novel Tools for Evaluation and Prediction of Radiotherapy Response in IndividualR01NS060752 · NINDS · UNIVERSITY OF WASHINGTON · PI SWANSON, KRISTIN R · 2009 to 2013
$1.6M
NCI NIH HHS R01 CA164371NCI NIH HHS U01 CA220378NCI NIH HHS U54 CA143970NCI NIH HHS U54 CA210180NINDS NIH HHS R01 NS060752
6 · The paper itself

Abstract

Although glioblastoma (GBM) is a fatal primary brain cancer with short median survival of 15 months, a small number of patients survive >5 years after diagnosis; they are known as extreme survivors (ES). Because of their rarity, very little is known about what differentiates these outliers from other patients with GBM. For the purpose of identifying unknown drivers of extreme survivorship in GBM, the ENDURES consortium (ENvironmental Dynamics Underlying Responsive Extreme Survivors of GBM) was developed. This consortium is a multicenter collaborative network of investigators focused on the integration of multiple types of clinical data and the creation of patient-specific models of tumor growth informed by radiographic and histologic parameters. Leveraging our combined resources, the goals of the ENDURES consortium are 2-fold: (1) to build a curated, searchable, multilayered repository housing clinical and outcome data on a large cohort of ES patients with GBM; and (2) to leverage the ENDURES repository for new insights into tumor behavior and novel targets for prolonging survival for all patients with GBM. In this article, the authors review the available literature and discuss what is already known about ES. The authors then describe the creation of their consortium and some preliminary results.

Indexed as

Brain NeoplasmsCancer SurvivorsGlioblastomaRegistriesAgedFemaleHumansInformation ManagementInterdisciplinary CommunicationIntersectoral CollaborationMaleMiddle AgedSurvival Rate

Identifiers

PMID31343422
PMCPMC7416695
OpenAlexW2964229415

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.